Standalone health insurers are requesting the IRDAI to exclude mandatory business lines from Expense of Management calculations to maintain a fair playing field. These specialized insurers argue that including products like motor third-party and government schemes makes it difficult to meet the proposed 25% expense limit. The move is aimed at protecting profitability for companies that focus primarily on retail health insurance.
Standalone health insurance companies are in discussions with the Insurance Regulatory and Development Authority of India (IRDAI) to refine how they calculate operating costs. The industry is asking the regulator to change the rules for the Expense of Management (EoM) limit, which sets a cap on how much an insurer can spend on operating costs, commissions, and other administrative expenses. The regulator has proposed a gradual reduction in these limits, aiming for a 25% cap within two years and 20% over a five-year period.
The core of the industry's request is to remove certain mandatory business lines from the calculation base. Standalone health insurers, such as Star Health, operate almost entirely in the retail health segment. In contrast, general insurance firms manage a much wider variety of products, including motor, crop, property, and government-sponsored schemes. Because of this, general insurers have a more diverse pool of premiums that can help balance out their overall expense ratios.
Industry leaders argue that including mandatory, low-commission products like motor third-party insurance or government health schemes in the calculation artificially inflates the total premium base used to determine compliance. By requesting to exclude these segments, health insurers hope to ensure that the regulatory cap more accurately reflects the actual costs of selling and managing retail health insurance policies. If the current proposal proceeds without these adjustments, executives fear it could create an uneven playing field where standalone health carriers struggle to absorb distribution costs compared to their diversified counterparts.
Additionally, the regulator is looking to change the calculation method from Gross Written Premium (GWP) to Gross Direct Premium Income (GDPI). This shift would specifically exclude reinsurance premiums, which are premiums passed on to other companies to cover risks. As the insurance sector prepares for these changes, the balance between keeping consumer premiums affordable and maintaining sustainable profit margins for insurers remains the main point of negotiation. For investors, the outcome of these discussions will be important, as changes to these expense limits directly impact the operating margins and long-term business strategy of specialized health insurance companies. The next steps will depend on the final methodology adopted by the IRDAI, which will dictate how strictly these expense caps apply to different segments of the insurance market.